Sarepta Therapeutics, Inc. (SRPT) is a Medical Research and Drug Development Company with corporate offices and research facilities in Cambridge, Massachusetts, United States. The company made headlines in 2003 when it announced work on treatments for the severe acute respiratory syndrome (SARS) and the West Nile virus. SRPT’s primary products are based on Morpholino oligomers (PMOs), synthetic nucleic acid analogs that were conceived of by James Summerton and invented by
An American Medical Research and Drug Development Company faced challenges with Oracle ERP and SCM cloud. The company faced difficulties with cost accounting, account payables & receivables, and fixed asset management. Suneratech eliminated business disruption through continuous automated sanity & security testing, freed up key personnel to shift focus to business-critical tasks, and delivered business value. This resulted in 100% defect-free & on-time releases, increased speed of new feature adoption, and a 55% quality cost reduction.
